671 related articles for article (PubMed ID: 3013921)
21. [Thyroid uptake of I131 in iodine-induced thyroid pathology caused by amiodarone].
Piga M; Bartalena L; Mariotti S; Aghini-Lombardi F; Ceccarelli C; Lippi F; Loviselli A; Braverman L; Safran M; Pinchera A
Recenti Prog Med; 1988 Apr; 79(4):151-5. PubMed ID: 3393723
[No Abstract] [Full Text] [Related]
22. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
23. Effect of amiodarone on thyroid hormone economy.
Posner J; Sobel RJ; Glick S
Isr J Med Sci; 1984 Feb; 20(2):113-7. PubMed ID: 6423565
[TBL] [Abstract][Full Text] [Related]
24. [Amiodarone and the thyroid gland].
Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
[TBL] [Abstract][Full Text] [Related]
25. Effect of iodine restriction on thyroid function in patients with primary hypothyroidism.
Kasagi K; Iwata M; Misaki T; Konishi J
Thyroid; 2003 Jun; 13(6):561-7. PubMed ID: 12930600
[TBL] [Abstract][Full Text] [Related]
26. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
Irimie A; Piciu D
Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
[TBL] [Abstract][Full Text] [Related]
27. Amiodarone and the thyroid.
Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
[TBL] [Abstract][Full Text] [Related]
28. Iodine kinetic studies during amiodarone treatment.
Rao RH; McCready VR; Spathis GS
J Clin Endocrinol Metab; 1986 Mar; 62(3):563-8. PubMed ID: 3944239
[TBL] [Abstract][Full Text] [Related]
29. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
30. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
31. Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5'-monophosphate- and iodine-independent mechanism.
Tedelind S; Larsson F; Johanson C; van Beeren HC; Wiersinga WM; Nyström E; Nilsson M
Endocrinology; 2006 Jun; 147(6):2936-43. PubMed ID: 16527845
[TBL] [Abstract][Full Text] [Related]
32. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases.
Martino E; Aghini-Lombardi F; Mariotti S; Bartalena L; Lenziardi M; Ceccarelli C; Bambini G; Safran M; Braverman LE; Pinchera A
Clin Endocrinol (Oxf); 1987 Feb; 26(2):227-37. PubMed ID: 3665117
[TBL] [Abstract][Full Text] [Related]
33. Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
Borowski GD; Garofano CD; Rose LI; Spielman SR; Rotmensch HR; Greenspan AM; Horowitz LN
Am J Med; 1985 Mar; 78(3):443-50. PubMed ID: 3976702
[TBL] [Abstract][Full Text] [Related]
34. [Thyrotoxicosis, then hypothyroidism caused by iodine overload (amiodarone) associated with neuropathy. Failure of plasma exchange].
Patte D; Léger FA; Savoie JC; Ménage JJ; Samson Y; Nivet M; Goulon M
Ann Med Interne (Paris); 1983; 134(1):31-4. PubMed ID: 6305250
[TBL] [Abstract][Full Text] [Related]
35. Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.
Stäubli M; Studer H
Klin Wochenschr; 1985 Feb; 63(4):168-75. PubMed ID: 3920432
[TBL] [Abstract][Full Text] [Related]
36. [Usefulness of thyroid scintigraphy in the therapeutic management of amiodarone-induced hyperthyroidism].
Pacheco Capote C; Mena Bares LM; Benítez Velazco A; Louhibi Rubio L; Contreras Puertas PI; Maza Muret FR; Latre Romero JM
Rev Esp Med Nucl; 2007; 26(5):270-6. PubMed ID: 17910835
[TBL] [Abstract][Full Text] [Related]
37. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
[TBL] [Abstract][Full Text] [Related]
38. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
39. The effects of amiodarone on the thyroid.
Martino E; Bartalena L; Bogazzi F; Braverman LE
Endocr Rev; 2001 Apr; 22(2):240-54. PubMed ID: 11294826
[TBL] [Abstract][Full Text] [Related]
40. Goitre and thyroid dysfunction during chronic amiodarone treatment.
Eason RJ; Croxson MS; Lim TM; Evans MC; Cooper GJ
N Z Med J; 1984 Apr; 97(753):216-9. PubMed ID: 6585712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
